Cargando…
IgM to phosphatidylcholine in multiple sclerosis patients: from the diagnosis to the treatment
Multiple sclerosis (MS) is a demyelinating and neurodegenerative disease of the central nervous system. It affects young people, and a considerable percentage of patients need the help of a wheelchair in 15 years of evolution. Currently, there is not a specific technique for the diagnosis of MS. The...
Autores principales: | Sánchez-Vera, Isabel, Escudero, Esther, Muñoz, Úrsula, Sádaba, María C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437209/ https://www.ncbi.nlm.nih.gov/pubmed/37599706 http://dx.doi.org/10.1177/17562864231189919 |
Ejemplares similares
-
Serum levels of IgM to phosphatidylcholine predict the response of multiple sclerosis patients to natalizumab or IFN-β
por: Muñoz, Úrsula, et al.
Publicado: (2022) -
High prevalence of intrathecal IgA synthesis in multiple sclerosis patients
por: Muñoz, Úrsula, et al.
Publicado: (2022) -
Serum antibodies to phosphatidylcholine in MS
por: Sádaba, Maria Cruz, et al.
Publicado: (2020) -
Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA, and IgM in multiple sclerosis
Publicado: (1986) -
Cerebrospinal Fluid IgM Levels in Association With Inflammatory Pathways in Multiple Sclerosis Patients
por: Magliozzi, Roberta, et al.
Publicado: (2020)